OMJJARA
"OMJJARA" is a word mark owned by GlaxoSmithKline LLC, filed at IP Australia on June 16, 2022. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since May 5, 2023
- Filed
- June 16, 2022
- Registered
- June 16, 2022
- Expires
- June 16, 2032
- Application no.
- 2277393
- Registration no.
- 2277393
- Office
- IP Australia
- IP Australia
- Mark type
- Word mark
- 3 classes
Who owns OMJJARA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
GlaxoSmithKline LLC
Wilmington, United States
Representative
Davies Collison Cave Pty Ltd
Davies Collison Cave Pty Ltd
What the mark covers
The products and services OMJJARA is filed for, grouped by Nice class.
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; scientific research and development; scientific laboratory services; medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
Medical services; medical testing services; DNA screening and analysis services for medical purposes
What has happened so far
Steps recorded by IP Australia, newest first.
- Customer Amendment Made correspondence sent
- Full Assignment Requested
- Customer Amendment Made correspondence sent
- Amendment to Amend Owner Requested
- Amendment to Amend Owner Requested
- IP Right Registered correspondence sent
- Amendment to Amend Owner Requested
- Application Accepted correspondence sent
- Awaiting examination
- Application Received
About OMJJARA
Who owns the trademark "OMJJARA"?
IP Australia trademark "OMJJARA" (application 2277393) is owned by GlaxoSmithKline LLC.
What is the status of "OMJJARA"?
Its status at IP Australia is: registered.
When was "OMJJARA" registered?
It was registered on June 16, 2022 and is due to expire on June 16, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull OMJJARA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019dfc85-430c-77ae-8c28-12524fae877b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019dfc85-430c-77ae-8c28-12524fae877b",
"object": "trademark",
"mark_text": "OMJJARA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "AU",
"application_number": "2277393",
"filing_date": "2022-06-16",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "GlaxoSmithKline LLC",
"entity_id": "ent_019ebbad-4be6-7544-bafb-06b4c2a2ecb2"
}
]
}